Biocon Biologics
Tejas Talati is an experienced professional with a strong background in financial risk management, data strategies, big data analytics, advanced analytics strategies, and data warehousing. Currently serving as the Senior Director and Head of Enterprise Architecture, Data and Analytics at Biocon Biologics, Tejas has also held positions such as Vice President at Teneo and Senior Manager at EY. With a Master of Science in Information Technology and a Bachelor's degree in Chemical Engineering, Tejas has led multiple project lifecycles and developed various reporting and analytics solutions across industries such as financial services, hospitality, and telecommunications.
This person is not in any offices
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics